Quick Answer
Tenaya Therapeutics, Inc. reported Stockholders Equity of $123.27 million for fiscal year 2025.
Tenaya Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $123.27M | +32.8% |
| 2024 | $92.85M | -33.4% |
| 2023 | $139.42M | -42.7% |
| 2022 | $243.38M | -12.6% |
| 2021 | $278.53M | +442.5% |
| 2020 | -$81.31M | -85.9% |
| 2019 | -$43.74M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $82.87M | -26.4% | -17.0% |
| June 30, 2025 | $99.83M | -25.5% | -16.4% |
| March 31, 2025 | $119.40M | -24.5% | +28.6% |
| December 31, 2024 | $92.85M | -33.4% | -17.5% |
| September 30, 2024 | $112.60M | -31.7% | -16.0% |
| June 30, 2024 | $134.00M | -29.5% | -15.3% |
| March 31, 2024 | $158.18M | -26.6% | +13.5% |
| December 31, 2023 | $139.42M | -42.7% | -15.4% |
- Tenaya Therapeutics, Inc. showed an increase of +32.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Tenaya Therapeutics, Inc.’s stockholders equity has grown by 381.8% (from -$43.74 million to $123.27 million).
- The most recent figure is from Tenaya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: